A vaccine manufacturer in India has filed a defamation lawsuit against researchers and the editor of an international journal after they published a study reporting adverse events following COVID-19 vaccination.
The study focused on Covaxin, one of India's homegrown vaccines, and found that serious adverse events might not be uncommon and could persist for a significant period.
The manufacturer demanded the retraction of the article and claimed that the study was poorly designed and flawed. The researchers have stood by the integrity of their data and refuted the allegations, stating that the study did not establish a definitive link with the vaccine.
In response, the journal's editor has agreed to retract the article, which has raised concerns about editorial policies and ethical publication practices. The defamation proceedings are ongoing, and over 250 scientists and researchers have signed an open letter demanding the withdrawal of the lawsuit and the preservation of the study.
